Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2016 Jan 11;291(10):5138–5145. doi: 10.1074/jbc.M115.712075

Structure of the Regulator of G Protein Signaling 8 (RGS8)-Gαq Complex

MOLECULAR BASIS FOR Gα SELECTIVITY*

Veronica G Taylor ‡,§, Paige A Bommarito , John J G Tesmer ‡,1
PMCID: PMC4777848  PMID: 26755720

Abstract

Regulator of G protein signaling (RGS) proteins interact with activated Gα subunits via their RGS domains and accelerate the hydrolysis of GTP. Although the R4 subfamily of RGS proteins generally accepts both Gαi/o and Gαq/11 subunits as substrates, the R7 and R12 subfamilies select against Gαq/11. In contrast, only one RGS protein, RGS2, is known to be selective for Gαq/11. The molecular basis for this selectivity is not clear. Previously, the crystal structure of RGS2 in complex with Gαq revealed a non-canonical interaction that could be due to interfacial differences imposed by RGS2, the Gα subunit, or both. To resolve this ambiguity, the 2.6 Å crystal structure of RGS8, an R4 subfamily member, was determined in complex with Gαq. RGS8 adopts the same pose on Gαq as it does when bound to Gαi3, indicating that the non-canonical interaction of RGS2 with Gαq is due to unique features of RGS2. Based on the RGS8-Gαq structure, residues in RGS8 that contact a unique α-helical domain loop of Gαq were converted to those typically found in R12 subfamily members, and the reverse substitutions were introduced into RGS10, an R12 subfamily member. Although these substitutions perturbed their ability to stimulate GTP hydrolysis, they did not reverse selectivity. Instead, selectivity for Gαq seems more likely determined by whether strong contacts can be maintained between α6 of the RGS domain and Switch III of Gαq, regions of high sequence and conformational diversity in both protein families.

Keywords: crystal structure, GTPase-activating protein (GAP), heterotrimeric G protein, regulator of G protein signaling (RGS), structure-function, X-ray crystallography, Gq, RGS10, RGS8, selectivity, cell signaling, protein structure, cardiovascular disease, protein complex, GTPase activation assays, Gαq

Introduction

Many transmembrane signaling events are transduced inside the cell by heterotrimeric G proteins, which are activated by cell surface G protein-coupled receptors. G protein-coupled receptors stimulate the exchange of bound GDP for GTP on the Gα subunit, which then separates from the Gβγ subunits and interacts with downstream effectors (1). After hydrolyzing GTP to GDP, the Gα subunit is deactivated and is rapidly sequestered by Gβγ. In biological processes, such as the visual response, deactivation of Gα has been observed at much faster rates than those measured for isolated Gα subunits in vitro (2, 3). This discrepancy helped lead to the discovery of a family of GTPase-activating proteins (GAPs),2 now known as regulator of G protein signaling (RGS) proteins (46). RGS proteins contain a conserved helical domain called the RGS domain that directly binds to the three switch regions (SwI–III) of the Gα subunit and stabilizes them in a transition state conformation (7).

RGS domains are divided into four subfamilies based on sequence homology and substrate preference: RZ, R4, R7, and R12 (8). All utilize Gαi/o subunits as substrates, although some RZ members seem selective for Gαz subunits (9). A recent study using surface plasmon resonance indicated that the RGS domains that belong to the R7 and R12 subfamilies bind weakly or not at all to Gαq, whereas the RZ and R4 subfamilies tend to interact with both Gαi/o and Gαq/11 (10). The exception is RGS2, an R4 subfamily member that is uniquely selective for Gαq/11 (11). The underlying molecular mechanism dictating RGS selectivity has not been fully answered, and past research has focused mainly on RGS2 in part because of its strong link to hypertension and cardiac hypertrophy via its regulation of Gαq signaling in vivo (1216). RGS2 can be altered to enhance its selectivity for Gαi/o by making mutations at three positions unique to RGS2 (Cys106, Asn184, and Glu191) that interact with the G protein, primarily near the SwI region (11). These residues are conserved as Ser, Asp, and Lys, respectively, in other RGS proteins. The crystal structure of an RGS2 mutant with conversion of these three residues to their equivalents in other RGS domains (RGS2SDK) in complex with Gαi confirmed that the mutant binds in the same canonical orientation as observed in other RGS-Gαi/o complexes (17).

Subsequently, the structure of wild-type RGS2 in complex with Gαq revealed a distinct binding mode (18). Because this was also the first RGS domain-Gαq complex to be structurally characterized, it was unclear whether the significant tilt in the orientation of the RGS domain with respect to Gα was due to sequence differences in either RGS2 or Gαq. Therefore, before one can address the molecular basis for why some RGS proteins select against Gαq/11 subfamily members, structures of conventional R4 subfamily members in complex with Gαq need to be determined.

Herein, we show that RGS8, an R4 subfamily member, binds to Gαq in a manner similar to how other RGS proteins bind Gαi/o, indicating that the distinct pose of RGS2 is driven by its unique switch binding residues. We investigate unique contacts formed between RGS8 and the Gα α-helical domain and demonstrate that although residues in the α-helical domain modulate GAP activity, the chief determinant of selectivity is found elsewhere, most likely SwIII. These results clarify the molecular determinants of RGS domain selectivity and, by extension, how RGS proteins impact signaling pathways in vivo.

Experimental Procedures

Protein Expression and Purification

All constructs encoding RGS variants were confirmed by sequencing on both strands. Residues 42–173 spanning the RGS domain of RGS8 were expressed using the pQTEV vector (a kind gift from Dr. R. Neubig, Michigan State University). Residues 22–157 spanning the RGS domain of RGS10 were expressed using a pLIC-SGC1 vector obtained from the Structural Genomics Consortium (10). After cleaving the N-terminal His6 tag with tobacco etch virus protease from RGS8 and RGS10, the exogenous sequence QSM is left on the N terminus.

For RGS8 variants, 1 liter of BL21 Rosetta cells grown in Terrific Broth was induced with 100 μm isopropyl-1-thio-β-d-galactopyranoside at 20 °C. The cells were pelleted by centrifugation at 3500 × g for 15 min and then resuspended in Buffer A (20 mm HEPES, pH 8.0, 500 mm NaCl, and 10 mm β-mercaptoethanol), supplemented with 7.6 μm leupeptin, 360 nm lima bean trypsin inhibitor, 1 mm PMSF, and 0.1 mm EDTA before being homogenized with a Dounce. Cells were then lysed using an EmulsiFlex-C3 homogenizer (Avestin). Cell debris was pelleted by centrifugation at 40,000 rpm (185,500 g) in a Type 45 Ti fixed angle rotor (Beckman-Coulter). The supernatant was passed over a 5-ml Ni-NTA affinity column pre-equilibrated with Buffer A. The column was then washed with 100 ml of Buffer A, followed by 100 ml of Buffer A with 10 mm imidazole, pH 8.0. RGS8 was eluted from the affinity column using 25 ml of Buffer A with 150 mm imidazole, pH 8.0, and then dialyzed into 20 mm sodium acetate, pH 5.5, 0.5 m NaCl, and 10 mm β-mercaptoethanol. The salt concentration was reduced by diluting 4-fold into Buffer B (20 mm sodium acetate, pH 5.5, and 2 mm DTT), and the protein was loaded onto an UnoS ion-exchange column (Bio-Rad) and eluted using Buffer B in an NaCl gradient increasing from 125 mm to 1 m. Fractions absorbing at 280 nm were verified using SDS-PAGE and pooled and concentrated to 4–9.5 mg/ml. For cleavage of the His tag, 2% (w/w) tobacco etch virus protease was added during a final dialysis into Buffer A.

RGS10 variants were expressed and purified similarly to RGS8 until after elution from the Ni-NTA affinity column. Cleavage of the His6 tag was then performed as described above for RGS8, followed by passage over a second Ni-NTA affinity column to remove the cleaved tag and His6-tagged protease. The flow-through was collected, concentrated to ∼7.5 mg/ml, and then buffer-exchanged on tandem Superdex 200 10/300 GL (GE Life Sciences) gel filtration columns into Buffer A with 5 mm DTT instead of β-mercaptoethanol. Fractions absorbing at 280 nm were verified using SDS-PAGE and then pooled and concentrated to 7.5–9 mg/ml.

The insect cell vector pFastBacHT expressing an N-terminally truncated variant of Mus musculusq spanning residues 35–359 (ΔN-Gαq) was described previously (18). For purification, 6 liters of High FiveTM cells (BTI-TN-5B1-4) expressing ΔN-Gαq were pelleted at 3000 × g for 20 min. The pellet was then resuspended in Buffer A (20 mm HEPES, pH 8.0, 100 mm NaCl, 10 mm β-mercaptoethanol, and 10 μm GDP, pH 8.0), 7.6 μm leupeptin, 360 nm lima bean trypsin inhibitor, 1 mm PMSF, 0.1 mm EDTA, and 3 mm MgCl2. Cells were then homogenized, lysed, and pelleted as described for RGS8. The supernatant was then passed through a Ni-NTA agarose affinity column pre-equilibrated with Buffer A supplemented with 1 mm MgCl2. The column was washed with 100 ml of Buffer A plus 1 mm MgCl2, followed by 100 ml of Buffer A plus 1 mm MgCl2 and 10 mm imidazole, pH 8.0, and then eluted with 25 ml of Elution Buffer (Buffer A with 1 mm MgCl2 and 150 mm imidazole, pH 8.0). Gαi/q-R183C was produced as described previously (19).

The Escherichia coli vector pQE60 expressing a C-terminal, His6-tagged Gαi1 spanning residues 1–354 was provided courtesy of Dr. Barry Kreutz (University of Illinois at Chicago). Expression was carried out as described previously (20). Purification was similar to RGS8, with the following exceptions. The Lysis Buffer was 50 mm HEPES, pH 8.0, 1 mm EDTA, 2 mm DTT, 0.1 mm PMSF, 7.6 μm leupeptin, and 360 nm lima bean trypsin inhibitor. Buffer A was 50 mm HEPES, pH 8.0, and 2 mm DTT. After washing the Ni-NTA affinity column with Buffer A, the elution step was performed using Elution Buffer (50 mm HEPES, pH 8.0, 2 mm DTT, and 150 mm imidazole, pH 8.0). The eluate was then loaded onto a UnoQ anion exchange chromatography column (Bio-Rad) pre-equilibrated with Buffer A and eluted using a gradient of 0–250 mm NaCl in Buffer A. The integrity of Gαi1 was confirmed by visualizing trypsin digests on SDS-PAGE as described previously (21).

Purification of the RGS8-Gαq Complex

Purified ΔN-Gαq was incubated with 30 μm AlCl3, 10 mm NaF, and 1 mm MgCl2 in a buffer also containing 10 μm GDP, pH 8.0, 20 mm HEPES, pH 8, 100 mm NaCl, and 2 mm DTT. It was then mixed with purified RGS8 in a 1:1 molar ratio based on the RGS8 concentration determined using a NanoDropTM ND-1000 spectrophotometer, and the ΔN-Gαq concentration was determined using Bradford reagent. The proteins were incubated together for 30 min on ice before loading onto tandem Superdex 200 10/300 GL (GE Life Sciences) gel filtration columns equilibrated with 20 mm HEPES, pH 8.0, 100 mm NaCl, 2 mm DTT, 10 μm GDP, pH 8.0, and 1 mm MgCl2. Fractions shown to contain 1:1 complex by SDS-PAGE were then concentrated to 5–7 mg/ml.

Crystallization and Cryoprotection

Crystals were grown in VDX plates (Hampton Research) using hanging drop vapor diffusion on glass cover slides. The RGS8-Gαq complex (6.6 mg/ml) was mixed 1:1 with well solution to a final volume of 1 μl and suspended over 1 ml of well solution. Octahedral crystals grew in 2 weeks at 4 °C using a well solution containing 0.1 m ammonium acetate, 0.1 m Bis-Tris, pH 5.5, and 11% PEG 8000. Crystals were harvested by adding several μl of cryoprotectant (20 mm HEPES, pH 8.0, 100 mm Bis-Tris, pH 5.4, 200 mm ammonium acetate, 15% PEG 8000, 200 mm NaCl, 1 mm DTT, 50 μm GDP, pH 8.0, 20 μm AlCl3, 10 mm NaF, and 5 mm MgCl2) in 0.5-μl increments to the drop containing the crystal. The crystal was then transferred into 100% cryoprotectant and moved stepwise through mixtures of cryoprotectant plus glycerol until a final glycerol concentration of 24% (v/v). The crystal was then suspended in a nylon loop and frozen in liquid nitrogen.

Data Collection, Processing, and Model Building

X-ray diffraction data were collected at the Life Sciences Collaborative Access Team (LS-CAT) beamline 21-ID-D at the Advanced Photon Source (APS). Reflection intensities were integrated and scaled using HKL2000, and initial phases were determined by molecular replacement using PHASER and structures of ΔN-Gαq from Protein Data Bank (PDB) entry 4EKD and RGS8 from PDB entry 2ODE as search models. Manual model building in Coot was alternated with TLS refinement with local non-crystallographic symmetry restraints in REFMAC5. Coordinates and structure factors were deposited with the Protein Data Bank as entry 5DO9. Figures were generated using The PyMOL Molecular Graphics System, Version 1.5.0.4 (Schrödinger, LLC).

GAP Assays

3 and 4 mg/ml stocks of Gαi/q-R183C and Gαi1, respectively, were incubated for 10 min with 10 mm EDTA, and then diluted to 0.3 μm final concentration in 300 μl of Incubation Buffer (50 mm HEPES, pH 8.0, 1 mm DTT, 1 mm EDTA, 100 μg/ml albumin, 5.5 mm CHAPS, 5% glycerol, and 37.5 μm ammonium sulfate) plus 33.3 μCi/ml [γ-32P]GTP (PerkinElmer, EasyTide) and enough cold GTP, pH 8.0, to make the total GTP concentration 6.25 μm. The reaction was then incubated at room temperature for 3 h (Gαi/q-R183C) or 30 min (Gαi1). Samples were buffer-exchanged into fresh Incubation Buffer using a pre-equilibrated Micro Bio-SpinTM chromatography column (Bio-Rad) and stored on ice for the duration of the assay. Each assay was initiated by adding 20 μl of the buffer-exchanged Gα subunit to a tube containing 100 nm RGS protein in 180 μl of Assay Buffer (20 mm HEPES, pH 8.0, 80 mm NaCl, 1 mm DTT, 1 mm EDTA, 0.9 mm MgCl2, 1 mm cold GTP, pH 8.0, 10 μg/ml albumin, and 0.20% w/v cholate) on ice. 40-μl aliquots of the reaction were quenched at various time points by vortexing with 750 μl of ice-cold Quenching Buffer (10 mm sodium phosphate, pH 2.0, and 5% (w/v) activated charcoal). The quenched reaction was spun for 25 min at 6500 × g at 4 °C. Afterward, 200 μl of the supernatant was added to 3 ml of MicroScintTM 40 scintillation mixture (Perkin-Elmer) and read on a liquid scintillation counter instrument measuring 32P cpm. Each RGS variant was tested in triplicate in three separate experiments. Data were processed in Prism 6 using a non-linear exponential fit with a time lag for Gαi1 or a straight line fit for Gαi/q-R183C.

Sequence Alignment and Structure Comparisons

Human RGS sequences from UniProt were aligned using Clustal Omega at the European Molecular Biology Laboratory-European Bioinformatics Institute (22). RMSD calculations were performed using Superpose from the CCP4 software suite (23, 24). Calculation of buried surface area for complexes was performed using PISA (25).

Results

Crystal Structure of the RGS8-Gαq Complex

To determine whether the altered pose of RGS2 on Gαq was due to the unique switch interface residues Cys106, Asn184, and Glu191 of RGS2 or to unique residues in the switch regions of Gαq relative to Gαi, the crystal structure of the RGS domain of RGS8, an R4 subfamily member selective for both Gαq and Gαi, was determined in complex with N-terminally truncated Gαq (ΔN-Gq). RGS8 was used because it readily crystallizes, and the structure of its complex with Gαi3 was previously reported (10). The final structure was refined to 2.6 Å spacings (Table 1, Fig. 1A). Residues 42–173 of RGS8 with two N-terminal exogenous residues are visible in all complexes, as well as residues 38–350 of ΔN-Gαq. Three complexes of RGS8-Gαq exist in the asymmetric unit, with their overall RMSD in Cα positions varying by less than 0.6 Å. Comparisons with the RGS8-Gαi3 and RGS2SDK-Gαi3 complexes give RMSD values of 0.9 Å for 432 and 426 Cα atoms, respectively, whereas comparison with the RGS2-Gαq complex gives an RMSD of 1.2 Å for 439 Cα atoms. This indicates that RGS8 binds Gαq in a manner most similar to how RGS proteins have previously been shown to bind Gαi/o subfamily members (Fig. 1B). Thus, the unique substitutions (Fig. 2A) in the Gα-binding interface of RGS2 are primarily responsible for its altered pose when bound to Gαq.

TABLE 1.

Crystallographic and refinement statistics for the RGS8-Gαq complex

Values in parentheses correspond to the highest resolution shell of data.

RGS8-Gαq
Data collection
    X-ray source APS 21 ID-D
    Wavelength (Å) 1.0383
    Dmin (Å) 30.0–2.60 (2.64–2.60)
    Space group C121
    Cell dimensions
        a, b, c (Å) 174.0, 95.9, 112.9
        β (°) 94.3
    Total reflections 211,145
    Unique reflections 56,869
    Rsym (%) 12.5 (58.5)
    Completeness (%) 99.3 (92.3)
    〈II 7.6 (4.1)
    Redundancy 3.7 (3.6)
    CC½a (71.5)

Refinement
    Refinement resolution (Å) 30.0–2.60 (2.66–2.60)
    Total reflections used 54,036 (3705)
    RMSD bond lengths (Å) 0.013
    RMSD bond angles (°) 1.584
    Estimated coordinate error (Å) 0.219
    Ramachandran plot
        Favored (%) 98.35
    Outliers (%) 0.00
    Rwork/Rfree (%) 17.8/22.5 (27.0/31.0)
    Protein atoms 11,092
    Ligand atoms 102
    Solvent molecules 231
    Average B-factor (Å2): 47.8
        Protein 48.2
        Ligand 27.1
        Solvent 37.7
    Wilson B factor (Å2) 37.5
    MolProbity score 1.39 (100th percentile)

PDB entry 5DO9

a CC½, Pearson correlation coefficient.

FIGURE 1.

FIGURE 1.

Structure of RGS8 in complex with Gαq reveals a canonical tilt. A, the 2.6 Å crystal structure of the RGS8 GAP domain in complex with ΔN-Gαq. The αB-αC loop exhibits structural differences between Gαi and Gαq that could dictate the selectivity of RGS proteins. RGS8 is cyan, Gαq is yellow, the three switch regions are red, GDP is black, AlF4 is green, Mg2+ is orange, and the αB-αC loop of Gαi is shown in pink (PDB code 2ODE). B, RGS2 adopts a unique tilt when bound to Gαq. The Gα subunits of the RGS2-Gαq complex (PDB code 4EKD), RGS8-Gαi complex (PDB code 2ODE), and RGS8-Gαq complex (PDB code 5DO9) were superimposed to compare the position of the RGS domain in each complex. Gαq is shown in yellow, Gαq-bound RGS8 is shown in pale cyan, Gαi-bound RGS8 is shown in orange, and RGS2 is shown in dark blue.

FIGURE 2.

FIGURE 2.

Sequence conservation of RGS8 residues in α6 and α7 suggests selectivity mechanisms. A, sequence alignment of the α6–9 regions of the R4, R7, and R12 subfamilies. Alignments were performed with Clustal Omega using human sequences. Residue positions important in Gαi interactions are in dark gray, discussed SwIII interacting residues are in purple, and the dyad that interacts with the α-helical domain is in green. B, SwIII interface for the RGS8-Gαq complex (PDB code 5DO9). RGS8 is in cyan, and Gαq is in yellow. C, SwIII interface for the RGS10-Gαi complex (PDB code 2IHB). RGS10 is in blue, and Gαi is in pink. The disordered α6 region of RGS10 is depicted as a dashed line.

Molecular Basis for RGS Subfamily Selectivity

Next, the structures of the RGS8-Gαi and RGS8-Gαq complexes were compared to identify RGS domain contacts with Gα that are distinct between the Gαi/o and Gαq/11 subfamilies. The structural element that differs most is the αB-αC loop in the α-helical domain. In the RGS8-Gαq complex, the αB-αC loop is less ordered when compared with the RGS8-Gαi complex based on temperature factors, but extends closer to the RGS protein, which creates additional buried surface area (Fig. 1A). In fact, RGS2 seems to exploit this surface to maintain greater buried accessible surface area with Gαq (2050 Å2) than does RGS8 (1900 Å2), or than does RGS8 in complex with Gαi (1650 Å2). RGS residues that would contact this loop exhibit sequence heterogeneity among the various RGS subfamilies (Fig. 2A). The R4 family has a conserved Glu-Lys dyad in the α7 helix (RGS8 residues 155–156), whereas RGS10, an R12 member, has Lys-Tyr (residues 131–132) (Figs. 2A and 3, A and B). Superposition of the Gα subunits in the RGS8-Gαq (Fig. 3A) and RGS10-Gαi (Fig. 3B) complexes suggests that charge repulsion and/or steric hindrance by this dyad could discourage binding of R12 family members to Gαq, as there is a charge reversal in the first position and introduction of a bulkier Tyr residue for Lys in the second (Fig. 3C). In comparison, modeling Glu-Lys for the Lys-Tyr dyad of RGS10 anticipates no overt issues with Gαi binding (Fig. 3D). R7 subfamily members instead have a Lys-(Lys/Ser) dyad (Fig. 2A). The subfamily-specific sequences of these dyads could therefore contribute to Gα selectivity. In support of this hypothesis, a previous study found that mutating these positions contributes to differences in GAP activity of various R4 family members on Gαo (26).

FIGURE 3.

FIGURE 3.

Structural models of interactions between RGS α7 and the α-helical domain of Gα. A, contacts of the RGS8 α7 helix with the α-helical domain of Gαq. B, contacts of the RGS10 α7 helix with Gαi (PDB entry 2IHB) C, contacts of the RGS10 α7 helix when modeled in complex with Gαq. For this model, the Gα subunits of the RGS10 (2IHB) and RGS8 (5DO9) complexes were superimposed to portray RGS10 in complex with Gαq. D, RGS10 K131E/Y132K double mutant modeled in complex with Gαi. RGS10 Lys131 and Tyr132 were mutated to their corresponding residues in RGS8 using PyMOL to show the hypothetical complex. RGS8 is shown in cyan, RGS10 is shown in blue, Gαq is shown in yellow, and Gαi is shown in pink. Oxygens are depicted in red, and nitrogens are depicted in cyan.

Functional Analysis of the α-Helical Domain Interface

The aforementioned α-helical domain interface was tested by site-directed mutagenesis followed by single turnover GTPase assays using [γ-32P]GTP (Table 2, Fig. 4). RGS8-Glu155 and/or Lys156 were converted to their analogous residues in RGS10 (Lys and Tyr, respectively). Complementary mutations were introduced in RGS10, mutating Lys131 and/or Tyr132 to Glu and Lys, respectively. If RGS selectivity for Gα subunits was achieved via ionic repulsion with the α-helical domain of Gαq, then mutation at the first position (E155K in RGS8, K131E in RGS10) would result in a selectivity switch. Selectivity achieved through steric pressure would be potentially altered by mutation at the second position (K156Y in RGS8, Y132K in RGS10). If both sterics and charge were necessary to affect a selectivity switch, then both point mutations (E155K/K156Y in RGS8 and K131E/Y132K in RGS10) would be required.

TABLE 2.

Single turnover GTPase assays using RGS8 and RGS10 variants

Values correspond to three experiments performed in triplicate for each mutant with each Gα subunit ± S.D. Prism 6 was used to calculate k values using one-phase association for Gαi and to calculate steady state rates using a straight line fit for Gαi/q-R183C.

i1 i/q-R183C
s1 fmol/s
No GAP 0.013 ± 0.002 <0.01
RGS8 WT 0.042 ± 0.023 0.07 ± 0.018
RGS8 E155K 0.051 ± 0.030 0.19 ± 0.0080
RGS8 K156Y 0.063 ± 0.037 0.15 ± 0.012
RGS8 E155K/K156Y 0.051 ± 0.007 0.29 ± 0.043

No GAP 0.007 ± 0.003 <0.01
RGS10 WT 0.034 ± 0.005 <0.01
RGS10 K131E 0.021 ± 0.004 <0.01
RGS10 Y132K 0.007 ± 0.001 <0.01
RGS10 K131E/Y132K 0.029 ± 0.008 <0.01
FIGURE 4.

FIGURE 4.

Single turnover GAP assays of RGS variants reveal modulation by contacts with the α-helical domain. A, representative data from three experiments performed in triplicate of RGS8 variants using Gαi as a substrate. Points were fit with a non-linear regression using one-phase association with a time lag. B, representative data from RGS8 variants using Gαq as a substrate. Points were fit with a single steady state rate. C, representative data from RGS10 variants using Gαi as a substrate. Error bars correspond to standard deviations. GTPase activity of the Gα subunit alone is indicated in pink, wild-type RGS is indicated in blue, RGS8 E155K or RGS10 K131E is indicated in green, RGS8 K156Y or RGS10 Y132K is indicated in orange, and RGS8 E155K/K156Y or RGS10 K131E/Y132K is indicated in red.

Wild-type Gαi1 and the slow-hydrolyzing mutant Gαi/q-R183C were used as substrates for each RGS variant. As expected, wild-type RGS8 showed robust GAP activity on both Gαi1 (Fig. 4A) and Gαi/q-R183C (Fig. 4B), whereas wild-type RGS10 only showed GAP activity on Gαi1 (Fig. 4C, Table 2). All three mutants of RGS8 retained their activity on Gαi1, but also retained wild-type, if not higher, activity on Gαi/q-R183C. The RGS10 double mutant and K131E single mutant also retained activity on Gαi3. Interestingly, the Y132K mutant did not. None of the RGS10 mutants showed GΑP activity on Gαi/q-R183C. These results indicate that the RGS domain dyad that contacts the αB-αC loop is not responsible for RGS10 being inactive on Gαq, as RGS10 and RGS8 mutants had no increase or loss, respectively, in selectivity for Gαi/q-R183C.

Discussion

RGS proteins range from being relatively small proteins with little more than the RGS domain, to complex multi-domain entities with multiple signaling domains. However, even in simple RGS proteins such as RGS2, RGS4, and RGS8, the regions outside the RGS domain can play important roles such as targeting these enzymes to membranes, G protein-coupled receptors, or effector enzymes (2730). Thus, when one considers the selectivity of an RGS protein for a particular Gα signaling pathway, there are many levels at which this can occur. However, the most fundamental aspect of selectivity is imposed by the direct interaction of the RGS domain with Gα to promote acceleration of GTP hydrolysis. Consequently, this study focused solely on the interaction of the RGS domain found in RGS proteins with Gαi and Gαq subunits. Moreover, previous studies have shown that isolated RGS domains exhibit selectivity for individual Gα subfamilies (10).

Previous structural analysis of the RGS2 complex with Gαq suggested that RGS2 has a distinct tilt relative to the Gα subunit (Fig. 1B) that allows it to bury more surface area with Gαq than it could with Gαi. Moreover, the conformationally flexible α6 helix of RGS2 allows it to maintain optimal contacts with SwIII, despite the unique pose of the RGS domain (18). When the Cys106, Asn184, and Glu191 interface residues are mutated to their equivalents in other RGS proteins in RGS2SDK, it can bind to Gαi in a canonical fashion (17), but does not lose activity against Gαq, suggesting that interactions with SwI are not directly responsible for Gαq selectivity (11, 17). It was further demonstrated that altering interactions between the α7 helix of the RGS2 domain and the α-helical domain of Gα can dramatically promote or inhibit GAP activity (18), but the molecular basis for selectivity against Gαq observed in other RGS subfamilies remained unclear.

In this work, it was shown that an R4 family member, RGS8, binds to Gαq in a canonical fashion, permitting a more precise comparison of the interactions between RGS proteins and these two Gα subfamilies. The tilt of RGS2 in complex with Gαq can thus be attributed to interfacial differences dictated by unique interfacial residues in RGS2. Two regions, in particular the αB-αC loop of the α-helical domain, stand out as a potential selectivity determinant. The G protein α-helical domain has previously been shown in some instances to be a major determinant of GAP activity, and there are sequence signatures unique to each RGS subfamily that interact with this domain (18, 31). Although a selectivity switch was not achieved in our study, the GAP assay results are consistent with RGS activity being enhanced or inhibited by interactions with the α-helical domain. Interestingly, the RGS10 Y132K mutant, creating a Lys-Lys dyad in α7, did not retain activity for Gαi1, but could be rescued by the addition of the K131E mutation. The disadvantage of having a Lys-Lys dyad may be due to electrostatic repulsion between the adjacent positions or with the α-helical domain. However, it seems clear that the α-helical domain is not a major Gα selectivity determinant because no substitution in this interface could promote activity on Gαi/q-R183C by RGS10 (Table 2).

Instead, the evidence now points toward SwIII, which interacts with the N-terminal end of the RGS α6 helix, as being the primary determinant of selectivity, as suggested in Ref. 10. In SwIII, the side chain of Gαq-Asp243 stacks with the side chain of RGS8-Phe125. The analogous residue in Gαi, Glu238, cannot make this interaction because the backbone of its SwIII is positioned differently. Phe is shared by several other R4 family members at this position, but not by any R7 or R12 members (Fig. 2A). R4 RGS domains typically also have a basic residue, e.g. RGS8-Arg128, that is positioned to form a hydrogen bond with a backbone carbonyl of another SwIII residue in Gαq, Glu241. Members of the R7 and R12 subfamilies typically lack this basic residue. Notably, although the RGS region that comes in contact with SwIII is well ordered in complexes involving R4 family members (Fig. 2, B and C), the RGS10 α6 helix is disordered in its complex with Gαi, and thus contacts with SwIII are nearly entirely lost (Fig. 2C). It is therefore quite possible that loss of productive interactions with SwIII mediated by the α6 region are responsible for the inability of some RGS subfamilies to recognize Gαq. However, due to the poor sequence conservation and conformational heterogeneity of this region in R12 family members (R12 subfamily members also have a 1-residue deletion in the α6 helical region), it is not possible to easily test this hypothesis because conversion of SwIII contacts in RGS8 to those found in RGS10, and vice versa, is not possible by simple substitution.

Regardless, this model does not explain how RGS proteins in the R7 and R12 subfamilies retain activity for Gαi if they fail to make productive interactions with SwIII. These subfamilies may have optimized interactions in other contact regions (e.g. αA and other regions in the Gα α-helical domain), as has been shown for some R4 family members in determining their relative activity on members of the Gαi subfamily (26). This hypothesis is supported by the increased GAP activity observed for RGS8 variants that have RGS10 substitutions in α7, and decreased GAP activity for RGS10 variants with RGS8 substitutions (Table 2). This result is consistent with prior studies that have likewise probed positions in α7 and shown them to modulate RGS domain interactions and GAP activity (18, 26, 32). Another possible explanation might be found in the SwI interface. Gαq has Pro185, whereas Gαi has Lys180. The Gαi-Lys180 side chain buries more surface area with the RGS protein when compared with Pro185 in Gαq. Hence, if the interactions with SwIII are not strong, RGS proteins may be less active against Gαq as a result of less buried surface area with SwI. Indeed the specific activity of RGS4 is ∼10 times lower than wild type when using the Gαi-K180P variant as a substrate (33). Inversely, AlF4-activated Gαq-P185K can be pulled down by RGS2 in significantly greater amounts than wild-type Gαq (32).

In summary, the rules that dictate RGS domain selectivity for a given Gα subunit are complex. They involve leveraging beneficial versus negative interactions at different points of contact with the Gα subunits, as well as the ability of individual RGS proteins to undergo induced fit when required (18). However, the structure-function analysis reported here still points to the SwI and SwIII interactions as being the key determinants of selectivity for Gαi versus Gαq. Interactions with the α-helical domain can tune GAP activity (such as for RGS9 in the Gαi/o subfamily) or can even rescue RGS2 from loss of activity when it binds to Gαq (18). How is selectivity achieved for or against other Gα subfamilies? Gαs is not a substrate for any known RGS protein due to presence of Asp229 in SwII (Ser in Gαi and Gαq) (34). Gαz, a Gαi/o subfamily member, is the preferred substrate for RZ subfamily member RGS20, but the mechanism for this selectivity is unknown (35). A full understanding of the intricacies of how RGS proteins interact with Gα subunits is required if one seeks to design an RGS domain specific to a particular Gα subunit, or, conversely, a Gα subunit that is a specific substrate for a select subgroup of RGS proteins. These would serve as useful tools to decipher the roles of individual RGS proteins in cellular signaling.

Author Contributions

V. G. T. and J. J. G. T. designed the experiments, determined the x-ray structure, and prepared the manuscript. V. G. T. and P. A. B. purified the complex. P. A. B. crystallized the complex. V. G. T. purified proteins for, and performed and analyzed the GAP assays. All authors approved the final paper.

Acknowledgments

Use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U. S. DOE under Contract Number DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). This research used the DNA Sequencing Core of the Michigan Diabetes Research and Training Center supported by DK20572. We thank the LS CAT staff members at Argonne Photon Source for their help with data collection and Dr. Jennifer Cash for assistance with crystal structure determination.

*

This work was supported in part by National Institutes of Health Grants HL086865 and HL122416 (to J. J. G. T.) and by National Institutes of Health Training Grant T32GM008270 (to V. G. T.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.

The atomic coordinates and structure factors (code 5DO9) have been deposited in the Protein Data Bank (http://wwpdb.org/).

2
The abbreviations used are:
GAP
GTPase-activating protein
RGS
regulator of G protein signaling
Sw
switch
Ni-NTA
nickel-nitrilotriacetic acid
Bis-Tris
2-(bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)propane-1,3-diol
RMSD
root mean square deviation.

References

  • 1. Oldham W. M., and Hamm H. E. (2008) Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 9, 60–71 [DOI] [PubMed] [Google Scholar]
  • 2. Arshavsky V. Yu., Antoch M. P., Lukjanov K. A., and Philippov P. P. (1989) Transducin GTPase provides for rapid quenching of the cGMP cascade in rod outer segments. FEBS Lett. 250, 353–356 [DOI] [PubMed] [Google Scholar]
  • 3. Watson N., Linder M. E., Druey K. M., Kehrl J. H., and Blumer K. J. (1996) RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits. Nature 383, 172–175 [DOI] [PubMed] [Google Scholar]
  • 4. De Vries L., Zheng B., Fischer T., Elenko E., and Farquhar M. G. (2000) The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40, 235–271 [DOI] [PubMed] [Google Scholar]
  • 5. Dohlman H. G., Apaniesk D., Chen Y., Song J., and Nusskern D. (1995) Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 3635–3643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Koelle M. R., and Horvitz H. R. (1996) EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84, 115–125 [DOI] [PubMed] [Google Scholar]
  • 7. Tesmer J. J., Berman D. M., Gilman A. G., and Sprang S. R. (1997) Structure of RGS4 bound to AlF4-activated Giα1: stabilization of the transition state for GTP hydrolysis. Cell 89, 251–261 [DOI] [PubMed] [Google Scholar]
  • 8. Ross E. M., and Wilkie T. M. (2000) GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69, 795–827 [DOI] [PubMed] [Google Scholar]
  • 9. Mao H., Zhao Q., Daigle M., Ghahremani M. H., Chidiac P., and Albert P. R. (2004) RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling. J. Biol. Chem. 279, 26314–26322 [DOI] [PubMed] [Google Scholar]
  • 10. Soundararajan M., Willard F. S., Kimple A. J., Turnbull A. P., Ball L. J., Schoch G. A., Gileadi C., Fedorov O. Y., Dowler E. F., Higman V. A., Hutsell S. Q., Sundström M., Doyle D. A., and Siderovski D. P. (2008) Structural diversity in the RGS domain and its interaction with heterotrimeric G protein α-subunits. Proc. Natl. Acad. Sci. U.S.A. 105, 6457–6462 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Heximer S. P., Srinivasa S. P., Bernstein L. S., Bernard J. L., Linder M. E., Hepler J. R., and Blumer K. J. (1999) G protein selectivity is a determinant of RGS2 function. J. Biol. Chem. 274, 34253–34259 [DOI] [PubMed] [Google Scholar]
  • 12. Heximer S. P., Knutsen R. H., Sun X., Kaltenbronn K. M., Rhee M.-H., Peng N., Oliveira-dos-Santos A., Penninger J. M., Muslin A. J., Steinberg T. H., Wyss J. M., Mecham R. P., and Blumer K. J. (2003) Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111, 445–452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Tang K. M., Wang G.-r., Lu P., Karas R. H., Aronovitz M., Heximer S. P., Kaltenbronn K. M., Blumer K. J., Siderovski D. P., Zhu Y., and Mendelsohn M. E. (2003) Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9, 1506–1512 [DOI] [PubMed] [Google Scholar]
  • 14. Calò L. A., Pagnin E., Davis P. A., Sartori M., Ceolotto G., Pessina A. C., and Semplicini A. (2004) Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. J. Clin. Endocrinol. Metab. 89, 4153–4157 [DOI] [PubMed] [Google Scholar]
  • 15. Gu S., Tirgari S., and Heximer S. P. (2008) The RGS2 gene product from a candidate hypertension allele shows decreased plasma membrane association and inhibition of Gq. Mol. Pharmacol. 73, 1037–1043 [DOI] [PubMed] [Google Scholar]
  • 16. Takimoto E., Koitabashi N., Hsu S., Ketner E. A., Zhang M., Nagayama T., Bedja D., Gabrielson K. L., Blanton R., Siderovski D. P., Mendelsohn M. E., and Kass D. A. (2009) Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J. Clin. Invest. 119, 408–420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kimple A. J., Soundararajan M., Hutsell S. Q., Roos A. K., Urban D. J., Setola V., Temple B. R. S., Roth B. L., Knapp S., Willard F. S., and Siderovski D. P. (2009) Structural determinants of G-protein α subunit selectivity by regulator of G-protein signaling 2 (RGS2). J. Biol. Chem. 284, 19402–19411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Nance M. R., Kreutz B., Tesmer V. M., Sterne-Marr R., Kozasa T., and Tesmer J. J. G. (2013) Structural and functional analysis of the regulator of G protein signaling 2-Gαq. Structure 21, 438–448 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Shankaranarayanan A., Thal D. M., Tesmer V. M., Roman D. L., Neubig R. R., Kozasa T., and Tesmer J. J. G. (2008) Assembly of high order Gαq-effector complexes with RGS proteins. J. Biol. Chem. 283, 34923–34934 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Lee E., Linder M. E., and Gilman A. G. (1994) Expression of G-protein α subunits in Escherichia coli. Methods Enzymol. 237, 146–164 [DOI] [PubMed] [Google Scholar]
  • 21. Kleuss C., Raw A. S., Lee E., Sprang S. R., and Gilman A. G. (1994) Mechanism of GTP hydrolysis by G-protein α subunits. Proc. Natl. Acad. Sci. U.S.A. 91, 9828–9831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Sievers F., Wilm A., Dineen D., Gibson T. J., Karplus K., Li W., Lopez R., McWilliam H., Remmert M., Söding J., Thompson J. D., and Higgins D. G. (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539–539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Winn M. D., Ballard C. C., Cowtan K. D., Dodson E. J., Emsley P., Evans P. R., Keegan R. M., Krissinel E. B., Leslie A. G. W., McCoy A., McNicholas S. J., Murshudov G. N., Pannu N. S., Potterton E. A., Powell H. R., Read R. J., Vagin A., and Wilson K. S. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Krissinel E., and Henrick K. (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60, 2256–2268 [DOI] [PubMed] [Google Scholar]
  • 25. Krissinel E., and Henrick K. (2007) Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 [DOI] [PubMed] [Google Scholar]
  • 26. Kosloff M., Travis A. M., Bosch D. E., Siderovski D. P., and Arshavsky V. Y. (2011) Integrating energy calculations with functional assays to decipher the specificity of G protein-RGS protein interactions. Nat. Struct. Mol. Biol. 18, 846–853 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Zeng W., Xu X., Popov S., Mukhopadhyay S., Chidiac P., Swistok J., Danho W., Yagaloff K. A., Fisher S. L., Ross E. M., Muallem S., and Wilkie T. M. (1998) The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. J. Biol. Chem. 273, 34687–34690 [DOI] [PubMed] [Google Scholar]
  • 28. Hague C., Bernstein L. S., Ramineni S., Chen Z., Minneman K. P., and Hepler J. R. (2005) Selective inhibition of α1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J. Biol. Chem. 280, 27289–27295 [DOI] [PubMed] [Google Scholar]
  • 29. Santhappan R., Crowder A. T., Gouty S., Cox B. M., and Côté T. E. (2015) Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner. J. Neurochem. 135, 76–87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Salim S., Sinnarajah S., Kehrl J. H., and Dessauer C. W. (2003) Identification of RGS2 and type V adenylyl cyclase interaction sites. J. Biol. Chem. 278, 15842–15849 [DOI] [PubMed] [Google Scholar]
  • 31. Skiba N. P., Yang C. S., Huang T., Bae H., and Hamm H. E. (1999) The α-helical domain of Gαt determines specific interaction with regulator of G protein signaling 9. J. Biol. Chem. 274, 8770–8778 [DOI] [PubMed] [Google Scholar]
  • 32. Day P. W., Tesmer J. J. G., Sterne-Marr R., Freeman L. C., Benovic J. L., and Wedegaertner P. B. (2004) Characterization of the GRK2 binding site of Gαq. J. Biol. Chem. 279, 53643–53652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Posner B. A., Mukhopadhyay S., Tesmer J. J. G., Gilman A. G., and Ross E. M. (1999) Modulation of the affinity and selectivity of RGS protein interaction with Gα subunits by a conserved asparagine/serine residue. Biochemistry 38, 7773–7779 [DOI] [PubMed] [Google Scholar]
  • 34. Natochin M., and Artemyev N. O. (1998) A single mutation Asp229 → Ser confers upon Gsα the ability to interact with regulators of G protein signaling. Biochemistry 37, 13776–13780 [DOI] [PubMed] [Google Scholar]
  • 35. Tu Y., Wang J., and Ross E. M. (1997) Inhibition of brain Gz GAP and other RGS proteins by palmitoylation of G protein α subunits. Science 278, 1132–1135 [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES